 |
Editas Medicine
Last updated: October 09, 2024
Founders: Jennifer Doudna, Feng Zhang, Keith Joung
USA | Funding: $931.6M (+)
Website: http://www.editasmedicine.com/
Editas Medicine's mission is to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level.
Website: http://www.editasmedicine.com/
Editas Medicine's mission is to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level.
